Back

Mirati Therapeutics Quote, Financials, Valuation and Earnings

New Year, New Trades, Try A.I. Today

Learn to forecast trends with up to 87.4% proven accuracy -> Register Here

Buy

MRTX
Mirati Therapeutics

Last Price:

52.56

Seasonality Move:

-5.31%

7 Day Trial

ALL ACCESS PASS

$ 7

Global Leader In Plant Cell Biology Poised For Rapid Growth!

Click for more info and ADD THIS COMPANY TO YOUR WATCHLIST!

Mirati Therapeutics Price Quote

$52.56

-0.01 (-3.13%)

(Updated: February 4, 2023 at 4:25 AM ET)

Mirati Therapeutics Key Stats

Buy

Mirati Therapeutics (MRTX) is a Buy

Day range:

$51.62 - $53.55

52-week range:

$32.96 - $124.81

Dividend yield:

P/E ratio:

0.00

P/S ratio:

245.96

P/B ratio:

2.68%

Volume:

Avg. volume:

1.4M

1-year change:

-55.39%

Market cap:

$3B

Revenue:

$72.1M

EPS:

$-13.39

How Much Does Mirati Therapeutics Make?

How Much Are Mirati Therapeutics's Sales Annually?
MRTX Revenues are $72.1M
How Much Profit Does Mirati Therapeutics's Make A Year?
MRTX net income is -$582.5M

Is Mirati Therapeutics Growing As A Company?

What Is Mirati Therapeutics's Growth Rate Quarterly?
Quarterly YoY revenue growth is -0.92%
What Is Mirati Therapeutics's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%

Mirati Therapeutics Stock Price Performance

Did Mirati Therapeutics Stock Go Up Last Month?
Mirati Therapeutics share price went up by 12.69% last month
Did MRTX's Share Price Rise Over The Last Year?
MRTX share price fell by -55.39% over the past 1 year

What Is Mirati Therapeutics 52-Week High & Low?

What Is Mirati Therapeutics’s 52-Week High Share Price?
Mirati Therapeutics has traded as high as $124.81 over the past 52 weeks
What Is Mirati Therapeutics’s 52-Week Low Share Price?
Mirati Therapeutics has traded as low as $32.96 over the past 52 weeks

Mirati Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Mirati Therapeutics?

How Much Debt Does Mirati Therapeutics Have?
Total long term debt quarterly is $0
How Much Cash Does Mirati Therapeutics Have?
Cash and short term investments quarterly total is $1.2B
What Is Mirati Therapeutics’s Book Value Per Share?
Book value per share is 19.61

Is Mirati Therapeutics Cash Flow Positive?

What Is MRTX Cash Flow From Operations?
Cash flow from operations (TTM) is -$579.8M
What Is Mirati Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $640.3M
What Is Mirati Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$4.3M

Mirati Therapeutics Return On Invested Capital

Is Management Doing A Good Job?
MRTX return on invested capital is -61.93%
What Is Mirati Therapeutics Return On Assets?
ROA measures how assets are converting to revenues and is -54.02%
What Is MRTX Return On Equity?
ROE is a measure of profitability and is -61.93%

Mirati Therapeutics Earnings Date & Stock Price

What Is Mirati Therapeutics's Stock Price Today?
A single share of MRTX can be purchased today for 52.57
What Is Mirati Therapeutics’s Stock Symbol?
Mirati Therapeutics trades on the nasdaq under the ticker symbol: MRTX
When Is Mirati Therapeutics’s Next Earnings Date?
The next quarterly earnings date for Mirati Therapeutics is scheduled on February 28, 2023
When Is MRTX's next ex-dividend date?
Mirati Therapeutics's next ex-dividend date is February 6, 2023
How To Buy Mirati Therapeutics Stock?
You can buy Mirati Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

Mirati Therapeutics Competitors

Who Are Mirati Therapeutics's Competitors?
Below is a list of companies who compete with Mirati Therapeutics or are related in some way:
- Agilent Technologies Inc (A)
- Amgen Inc (AMGN)
- Baudax Bio Inc (BXRX)
- Gossamer Bio Inc (GOSS)
- Merck & Co Inc (MRK)

Mirati Therapeutics Dividend Yield